Structure Therapeutics (GPCR) Non-Current Assets (2022 - 2026)

Structure Therapeutics' Non-Current Assets history runs 5 years deep, the most recent figure standing at $17.5 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 3.54% year-over-year to $17.5 million; the TTM figure through Mar 2026 stood at $66.4 million (up 38.32% YoY), while the FY2025 annual figure was $13.6 million, up 12.34% from the prior year.
• Non-Current Assets for Q1 2026 stood at $17.5 million, up from $13.6 million in the prior quarter.
• The five-year high for Non-Current Assets was $18.1 million in Q3 2025, with the low at $1.2 million in Q1 2023.
• The 5-year median for Non-Current Assets is $9.5 million (2024), against an average of $10.3 million.
• The sharpest annual moves came in 2024 and 2026: Non-Current Assets surged 680.1% in 2024, then rose 3.54% in 2026.
• Structure Therapeutics' Non-Current Assets stood at $4.8 million in 2022, then jumped by 76.81% to $8.4 million in 2023, then jumped by 44.12% to $12.1 million in 2024, then climbed by 12.34% to $13.6 million in 2025, then rose by 28.73% to $17.5 million in 2026.
• Business Quant data shows GPCR's Non-Current Assets at $17.5 million in Q1 2026, $13.6 million in Q4 2025, and $18.1 million in Q3 2025.